HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors

INTRODUCTION: Neuroendocrine neoplasms (NENs) are a rare group of tumors exceptionally heterogeneous, with clinical presentation ranging from well differentiated more indolent tumors to poorly differentiated very aggressive forms. Both are often diagnosed after the metastatic spread and require appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liverani, Chiara, Spadazzi, Chiara, Ibrahim, Toni, Pieri, Federica, Foca, Flavia, Calabrese, Chiara, De Vita, Alessandro, Miserocchi, Giacomo, Cocchi, Claudia, Vanni, Silvia, Ercolani, Giorgio, Cavaliere, Davide, Ranallo, Nicoletta, Chiadini, Elisa, Prisinzano, Giovanna, Severi, Stefano, Sansovini, Maddalena, Martinelli, Giovanni, Bongiovanni, Alberto, Mercatali, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895371/
https://www.ncbi.nlm.nih.gov/pubmed/36743926
http://dx.doi.org/10.3389/fendo.2022.1045038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895371/
https://www.ncbi.nlm.nih.gov/pubmed/36743926
http://dx.doi.org/10.3389/fendo.2022.1045038

Ejemplares similares